Trial will use AI in breast cancer screenings

Nearly 700,000 women will take part in a trial to test how AI tools can be used to discover breast cancer cases earlier, the Department of Health and Social Care announced today (February 4, 2025).

Breast cancer is the most common type of cancer in women
Breast cancer is the most common type of cancer in women - AdobeStock

Thirty testing sites will be enhanced with digital AI technologies, ready to invite women already booked in for routine screenings on the NHS to take part.

The technology will assist radiologists in screening patients to identify changes in breast tissue that show possible signs of cancer.

Two specialists are currently needed per mammogram screening, but the new AI technology will enable one to complete the same mammogram screening process. If the trial is successful, DHSC believes it could free up hundreds of radiologists and other specialists to see more patients, tackle rising cancer rates, save more lives and cut waiting lists. 

MORE FROM ARTIFICIAL INTELLIGENCE

The EDITH trial (Early Detection using Information Technology in Health) is backed by £11m of government support via the National Institute for Health and Care Research (NIHR).

Breast cancer is the most common type of cancer in women, with around 55,000 people being diagnosed with the disease annually. Currently, women between the ages of 50 and 71 are invited to be screened every three years to help detect cases.

In a statement, Professor Lucy Chappell, chief scientific adviser at DHSC and CEO of the NIHR said: “This landmark trial could lead to a significant step forward in the early detection of breast cancer, offering women faster, more accurate diagnoses when it matters most.  

“It is another example of how NIHR research, shaped and funded by the public, is crucial for rigorously testing world-leading new technologies, such as AI, that can potentially save lives while reducing the burden on the NHS.”

The launch of the EDITH trial comes as cancer experts, people living with cancer, and medical professionals are invited to help shape the development of a new National Cancer Plan via the launch of a call for evidence, which is being announced later today.